X-Linked Retinitis Pigmentosa Market Forecast: Emerging Treatments Create New Growth Opportunities
NEWARK, Del., Aug. 21, 2026 — The global X-Linked Retinitis Pigmentosa Market is expanding as advances in gene therapy, genetic diagnosis, and specialized retinal delivery create new treatment opportunities for patients with RPGR-associated vision loss. According to Future Market Insights (FMI), the market is projected to grow from USD 348.9 million in 2026 to USD 1,143.1 million by 2036,...
0 Commentaires 0 Parts 5 Vue 0 Aperçu